MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹6,507 Cr | ₹5,664 Cr | ₹2,120 Cr | ₹1,863 Cr | ₹2,623 Cr |
What is the latest Total Current Liabilities ratio of MANKIND PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹6,507 Cr |
| Mar2025 | ₹5,664 Cr |
| Mar2024 | ₹2,120 Cr |
| Mar2023 | ₹1,863 Cr |
| Mar2022 | ₹2,623 Cr |
How is Total Current Liabilities of MANKIND PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹6,507 Cr | 14.90 | |
| Mar2025 | ₹5,664 Cr | 167.18 | |
| Mar2024 | ₹2,120 Cr | 13.77 | |
| Mar2023 | ₹1,863 Cr | -28.98 | |
| Mar2022 | ₹2,623 Cr | - | |
Compare Total Current Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹108,129.6 Cr | 2.9% | 5.4% | -3.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 2.9% |
5.4% |
-3.6% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses